Cargando…

OAB-046: COVID-19 infection in multiple myeloma patients – retrospective analysis of 371 Czech patients

BACKGROUND: COVID-19 disease caused by SARS-CoV-2 coronavirus has affected millions of people worldwide. The mortality of this infection varies with age and comorbidities up to more than 10% in very elderly population. The aim of our study was to determine the disease pattern and mortality rate amon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radocha, Jakub, Špička, Ivan, Pour, Luděk, Jelinek, Tomas, Jungova, Alexandra, Minarik, Jiri, Heindorfer, Adriana, Stejskal, Lukas, Ullrychova, Jana, Obernauerova, Jarmila, Kessler, Petr, Wrobel, Marek, Pavlíček, Petr, Sykora, Michal, Mikula, Peter, Maisnar, Vladimir, Hájek, Roman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580181/ http://dx.doi.org/10.1016/S2152-2650(21)02120-0

Ejemplares similares

Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies
por: Radocha, Jakub, et al.
Publicado: (2018)

Clinical characteristics and outcomes in risk-stratified patients with smoldering multiple myeloma: data from the Czech Republic Registry of Monoclonal Gammopathies
por: Sandecka, Viera, et al.
Publicado: (2023)

Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice
por: Minarik, Jiri, et al.
Publicado: (2021)

Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas
por: Stork, Martin, et al.
Publicado: (2022)

P1294: REAL-WORLD OUTCOMES OF 2149 NEWLY DIAGNOSED TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS
por: Popková, Tereza, et al.
Publicado: (2023)

Identification of patients at high risk of secondary extramedullary multiple myeloma development
por: Stork, Martin, et al.
Publicado: (2021)

Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis
por: Stork, Martin, et al.
Publicado: (2023)

Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neuropathy
por: Minarik, Jiri, et al.
Publicado: (2015)

Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy
por: Minarik, Jiri, et al.
Publicado: (2022)

P967: TUMOR BURDEN AS A CRITICAL PROGNOSTIC FACTOR OF PRIMARY EXTRAMEDULLARY DISEASE
por: Vlachová, M., et al.
Publicado: (2022)

Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data
por: Campioni, M., et al.
Publicado: (2019)

Development and validation of a novel risk stratification algorithm for relapsed multiple myeloma
por: Hájek, Roman, et al.
Publicado: (2019)

P944: REAL-WORLD PATIENT CHARACTERISTICS AND SURVIVAL OUTCOMES OF LENALIDOMIDE REFRACTORY VS. LENALIDOMIDE EXPOSED RRMM PATIENTS IN THE HONEUR FEDERATED DATA NETWORK
por: Spicka, Ivan, et al.
Publicado: (2023)

Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine
por: Zátopková, Martina, et al.
Publicado: (2022)

Plain language summary: does treatment with vibegron result in improvements in overactive bladder (OAB) symptoms that are meaningful to people with OAB?
por: Frankel, Jeffrey, et al.
Publicado: (2023)

AB33. Botox: the novel therapy for OAB
por: Deng, Donna
Publicado: (2014)

Urine Proteomic Study in OAB Patients—Preliminary Report
por: Futyma, Konrad, et al.
Publicado: (2020)

The emperor has no clothes: OAB can be cured surgically
por: Petros, Peter
Publicado: (2022)

Title unknown, CERN-ALEPH-96-046
por: Riu, I, et al.
Publicado: (1996)

Vibegron 50 mg Once Daily Improves OABSS, OAB-q SF Score in OAB Patients ≥80 Years Old in Real-World Clinical Settings and Switching from Other OAB Drugs May Reduce Residual Urine Volume
por: Kuno, Takahira, et al.
Publicado: (2023)

Centrosome associated genes pattern for risk sub-stratification in multiple myeloma
por: Kryukov, Fedor, et al.
Publicado: (2016)

Development of a core set of outcome measures for OAB treatment
por: Foust-Wright, Caroline, et al.
Publicado: (2017)

Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data)
por: Romanová, Gabriela, et al.
Publicado: (2023)

Genome-Wide Screening of Cytogenetic Abnormalities in Multiple Myeloma Patients Using Array-CGH Technique: A Czech Multicenter Experience
por: Smetana, Jan, et al.
Publicado: (2014)

Physics at collider energies (CERN-PRE-82-046)
por: Jacob, Maurice René Michel
Publicado: (1982)

FRI046 Clinical Phenotyping Of Adults With Genetic Obesity
por: Welling, Mila Sofie, et al.
Publicado: (2023)

Import of West Nile Virus Infection in the Czech Republic
por: Hubálek, Zdenek, et al.
Publicado: (2006)

P34 LIGHTHOUSE (OP-108): MELFLUFEN PLUS DARATUMUMAB (DARA) AND DEXAMETHASONE (DEX) VERSUS DARA IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) REFRACTORY TO AN IMMUNOMODULATORY DRUG (IMID) AND A PROTEASOME INHIBITOR (PI) OR HAD RECEIVED ≥3 PRIOR LINES OF THERAPY INCLUDING AN IMID AND A PI
por: Mateos, M, et al.
Publicado: (2023)

MON-371 The Case of Dueling Femurs
por: Patel, Richa, et al.
Publicado: (2020)

Brain penetration of the OAB drug trospium chloride is not increased in aged mice
por: Kranz, Jasmin, et al.
Publicado: (2011)

P01-046 – Membrane aspects of Hemostasis disorders at ATYPIC
por: Ghazaryan, P, et al.
Publicado: (2013)

P046. ADHD and headache: observational study of case series
por: De Carlo, Debora, et al.
Publicado: (2015)

Mle046 Is a Marine Mesophilic MHETase-Like Enzyme
por: Meyer-Cifuentes, Ingrid E., et al.
Publicado: (2021)

Staple line leak with peritonitis after laparoscopic sleeve gastrectomy – a solution in one to six steps
por: Špička, Petr
Publicado: (2017)

Fungal Planet description sheets: 371–399
por: Crous, P.W., et al.
Publicado: (2015)

SAT-371 Severe Hypocalcemia Secondary to Pseudohypoparathyroidism
por: Ghanta, Neelima, et al.
Publicado: (2020)

Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma
por: Vlachová, Monika, et al.
Publicado: (2022)

Drug Delivery Approaches for Managing Overactive Bladder (OAB): A Systematic Review
por: Khizer, Zara, et al.
Publicado: (2021)

Decrease in the Ratio proBDNF/BDNF in the Urine of Aging Female Patients with OAB
por: Covarrubias, Claudia, et al.
Publicado: (2023)

Overexpression of ANAC046 Promotes Suberin Biosynthesis in Roots of Arabidopsis thaliana
por: Mahmood, Kashif, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_06g8f1dd75kcdpn9158bmij29j